Spinal muscular atrophy type 3

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is spinal muscular atrophy type 3?

Spinal Muscular Atrophy Type 3 is an inherited (genetic) condition that affects the nerve cells (motor neurons) in your spinal cord. Onset of this condition is usually from 2 and 17 years of age. The nerve cells tend to impair the legs, symptoms include, difficulty running and rising from a chair.

Common symptoms reported by people with spinal muscular atrophy type 3

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with spinal muscular atrophy type 3

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Klonopin)
Type
Prescription Drug
How many have tried
1
Tried for
anxious mood (1)
Treatment name(s)

(Neurontin)
Type
Prescription Drug
How many have tried
1
Tried for
anxious mood (1)
Treatment name(s)

(Pamelor)
Type
Prescription Drug
How many have tried
1
Tried for
depressed mood (1) pain (1)

Data from patients with spinal muscular atrophy type 3, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with spinal muscular atrophy type 3

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Klonopin)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
anxious mood (1)
Treatment name(s)

(Neurontin)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
anxious mood (1)
Treatment name(s)

(Pamelor)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
depressed mood (1) pain (1)
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with spinal muscular atrophy type 3, who reported starting treatments within the last 5 years.
Last updated:

Who has spinal muscular atrophy type 3 on PatientsLikeMe?


Age
Age Proportion # of patients
<20 4
20s 12
30s 7
40s 7
50s 7
60s 3
70+ 0
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 14
20-29 years 2
30-39 years 0
40-49 years 0
50-59 years 0
60-69 years 0
70+ years 0

Distribution of sex

Sex
Sex Proportion # of patients
Male 15
Female 25

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 16
Not Diagnosed 6

These charts show data from spinal muscular atrophy type 3 patients who have completed their condition history
Last updated: